Deletion and downregulation of MTAP contribute to the motility of esophageal squamous carcinoma cells

References

• TorreLABrayFSiegelRLFerlayJLortet-TieulentJJemalAGlobal cancer statistics, 2012CA Cancer J Clin20156528710825651787
   PubMed Web of Science ®Google Scholar
• FerlayJSoerjomataramIDikshitRCancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012Int J Cancer20151365E359E38625220842
   PubMed Web of Science ®Google Scholar
• PennathurAGibsonMKJobeBALuketichJDOesophageal carcinomaLancet2013381986440041223374478
   PubMed Web of Science ®Google Scholar
• MatsuyamaHIkemotoKEguchiSCopy number aberrations using multicolour fluorescence in situ hybridization (FISH) for prognostication in non-muscle-invasive bladder cancer (NIMBC)BJU Int2014113466266723890221
   PubMed Web of Science ®Google Scholar
• HidaTHamasakiMMatsumotoSImmunohistochemical detection of MTAP and BAP1 protein loss for mesothelioma diagnosis: comparison with 9p21 FISH and BAP1 immunohistochemistryLung Cancer20171049810528213009
   PubMedGoogle Scholar
• PereaJGarciaJLPerezJNOMO-1 gene is deleted in early-onset colorectal cancerOncotarget2017815244292443628416736
   PubMedGoogle Scholar
• CamposCZLosi GuembarovskiRde OliveiraCECGlutathione S-transferases deletions may act as prognosis and therapeutic markers in breast cancerClin Exp Med Epub2017428
   Google Scholar
• LinDCHaoJJNagataYGenomic and molecular characterization of esophageal squamous cell carcinomaNat Genet201446546747324686850
   PubMed Web of Science ®Google Scholar
• SongYLiLOuYIdentification of genomic alterations in oesophageal squamous cell cancerNature20145097498919524670651
   PubMed Web of Science ®Google Scholar
• HaoJJLinDCDinhHQSpatial intratumoral heterogeneity and temporal clonal evolution in esophageal squamous cell carcinomaNat Genet201648121500150727749841
   PubMed Web of Science ®Google Scholar
• LinDCWangMRKoefflerHPGenomic and epigenomic aberrations in esophageal squamous cell carcinoma and implications for patientsGastroenterology Epub2017727
   Google Scholar
• ShiZZShangLJiangYYConsistent and differential genetic aberrations between esophageal dysplasia and squamous cell carcinoma detected by array comparative genomic hybridizationClin Cancer Res201319215867587824009147
   PubMedGoogle Scholar
• KryukovGVWilsonFHRuthJRMTAP deletion confers enhanced dependency on the PRMT5 arginine methyltransferase in cancer cellsScience201635162781214121826912360
   PubMed Web of Science ®Google Scholar
• MavrakisKJMcDonaldER3rdSchlabachMRDisordered methionine metabolism in MTAP/CDKN2A-deleted cancers leads to dependence on PRMT5Science201635162781208121326912361
   PubMed Web of Science ®Google Scholar
• ZhaoMZhaoZConcordance of copy number loss and down-regulation of tumor suppressor genes: a pan-cancer studyBMC Genomics201617Suppl 753227556634
   PubMedGoogle Scholar
• KimDHMutoMKuwaharaYArray-based comparative genomic hybridization of circulating esophageal tumor cellsOncol Rep20061651053105917016592
   PubMed Web of Science ®Google Scholar
• SawadaGNiidaAUchiRGenomic landscape of esophageal squamous cell carcinoma in a Japanese populationGastroenterology201615051171118226873401
   PubMed Web of Science ®Google Scholar
• BassAJWatanabeHMermelCHSOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomasNat Genet200941111238124219801978
   PubMed Web of Science ®Google Scholar
• Cancer Genome Atlas Research Network; Analysis Working Group: Asan University; BC Cancer AgencyIntegrated genomic characterization of oesophageal carcinomaNature2017541763616917528052061
   PubMed Web of Science ®Google Scholar
• OrtizBWhiteJRWuWHChanTADeletion of Ptprd and Cdkn2a cooperate to accelerate tumorigenesisOncotarget20145166976698225138050
   PubMedGoogle Scholar
• McNealASLiuKNakhateVCDKN2B loss promotes progression from benign melanocytic nevus to melanomaCancer Discov20155101072108526183406
   PubMedGoogle Scholar
• YangHKircherDAKimKHActivated MEK cooperates with Cdkn2a and Pten loss to promote the development and maintenance of melanomaOncogene201736273842385128263969
   PubMedGoogle Scholar
• TuQHaoJZhouXCDKN2B deletion is essential for pancreatic cancer development instead of unmeaningful co-deletion due to juxtaposition to CDKN2AOncogene Epub2017911
   Google Scholar
• SchmidMMalickiDNoboriTHomozygous deletions of methylthioadenosine phosphorylase (MTAP) are more frequent than p16INK4A (CDKN2) homozygous deletions in primary non-small cell lung cancers (NSCLC)Oncogene19981720266926759840931
   PubMedGoogle Scholar
• HustinxSRHrubanRHLeoniLMHomozygous deletion of the MTAP gene in invasive adenocarcinoma of the pancreas and in periampullary cancer: a potential new target for therapyCancer Biol Ther200541838615662124
   PubMedGoogle Scholar
• KrasinskasAMBartlettDLCieplyKDacicSCDKN2A and MTAP deletions in peritoneal mesotheliomas are correlated with loss of p16 protein expression and poor survivalMod Pathol201023453153820081810
   PubMedGoogle Scholar
• SuCYChangYCChanYCMTAP is an independent prognosis marker and the concordant loss of MTAP and p16 expression predicts short survival in non-small cell lung cancer patientsEur J Surg Oncol20144091143115024969958
   PubMedGoogle Scholar
• HuangHYLiSHYuSCHomozygous deletion of MTAP gene as a poor prognosticator in gastrointestinal stromal tumorsClin Cancer Res200915226963697219887491
   PubMedGoogle Scholar
• CondeLVilasecaIAlosLMethylthioadenosine phosphorylase inactivation depends on gene deletion in laryngeal squamous cell carcinomaHistopathology20126161082108823020581
   PubMedGoogle Scholar
• CrespoITaoHNietoABAmplified and homozygously deleted genes in glioblastoma: impact on gene expression levelsPLoS One201279e4608823029397
   PubMedGoogle Scholar
• CzechBDettmerKVallettaDExpression and function of methylthioadenosine phosphorylase in chronic liver diseasePLoS One2013812e8070324324622
   PubMedGoogle Scholar
• MarceSBalagueOColomoLLack of methylthioadenosine phosphorylase expression in mantle cell lymphoma is associated with shorter survival: implications for a potential targeted therapyClin Cancer Res200612123754376116778103
   PubMedGoogle Scholar
• KimJKimMAMinSYJeeCDLeeHEKimWHDownregulation of methylthioadenosin phosphorylase by homozygous deletion in gastric carcinomaGenes Chromosomes Cancer201150642143321412930
   PubMedGoogle Scholar
• LiCFFangFMKungHJDownregulated MTAP expression in myxofibrosarcoma: a characterization of inactivating mechanisms, tumor suppressive function, and therapeutic relevanceOncotarget2014522114281144125426549
   PubMedGoogle Scholar
• MarjonKCameronMJQuangPMTAP deletions in cancer create vulnerability to targeting of the MAT2A/PRMT5/RIOK1 axisCell Rep201615357458727068473
   PubMed Web of Science ®Google Scholar
• JollyMKWareKEGiljaSSomarelliJALevineHEMT and MET: necessary or permissive for metastasis?Mol Oncol201711775576928548345
   PubMed Web of Science ®Google Scholar
• SantamariaPGMoreno-BuenoGPortilloFCanoAEMT: present and future in clinical oncologyMol Oncol201711771873828590039
   PubMed Web of Science ®Google Scholar
• ThieryJPEpithelial-mesenchymal transitions in tumour progressionNat Rev Cancer20022644245412189386
   PubMed Web of Science ®Google Scholar
• BolosVPeinadoHPerez-MorenoMAFragaMFEstellerMCanoAThe transcription factor Slug represses E-cadherin expression and induces epithelial to mesenchymal transitions: a comparison with Snail and E47 repressorsJ Cell Sci2003116Pt 349951112508111
   PubMed Web of Science ®Google Scholar
• ShihJYTsaiMFChangTHTranscription repressor slug promotes carcinoma invasion and predicts outcome of patients with lung adenocarcinomaClin Cancer Res200511228070807816299238
   PubMed Web of Science ®Google Scholar
• KaoSHWangWLChenCYGSK3beta controls epithelial-mesenchymal transition and tumor metastasis by CHIP-mediated degradation of SlugOncogene201433243172318223851495
   PubMedGoogle Scholar